Nestle Health Science / Seres Therapeutics

Nestlé Health Science (NHS), a leader in the science of nutrition, is a globally managed business unit of Nestlé.  NHS is committed to redefining the management of health, offering an extensive portfolio of science-based consumer health, medical nutrition, pharmaceutical therapies, and vitamin and supplement brands. Headquartered in Switzerland, NHS has more than 11,000 employees around the world, with products available in more than 140 countries. www.nestlehealthscience.com
Seres Therapeutics, Inc. (Seres) is a leading microbiome therapeutics company developing a novel class of multifunctional bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. www.serestherapeutics.com. Seres and NHS are collaborating on investigational therapeutic SER-109 in recurrent C. difficile infection.